10-Q: Vita Coco Reports Strong Branded Sales Growth Amidst Margin Pressures and Private Label Decline

Sentiment:

Quarterly Report


The Vita Coco Company, Inc. reported a 17.1% increase in net sales for the second quarter and first half of 2025, driven by robust Vita Coco Coconut Water volume, though gross margins compressed due to higher costs and tariffs, and private label sales declined.

Capital raiseThe company stated it 'may seek additional equity or debt financing in the future in order to acquire or invest in complementary businesses, products and/or new IT infrastructures.'
Worse than expectedGross margin decreased significantly from 40.8% to 36.3% in Q2 and from 41.4% to 36.5% in H1, primarily due to higher finished goods and transportation costs, and the initial impact of baseline tariffs.Income from operations decreased by 16.3% in Q2 and 9.2% in H1, despite strong top-line revenue growth, indicating increased operating expenses and margin pressures.Cash provided by operating activities decreased by 54.9% for the six months ended June 30, 2025, reflecting less efficient cash generation from core operations.Private label net sales experienced a substantial decline, indicating a loss of business in that segment.

Summary

  • Net sales increased 17.1% to $168.8 million for the three months ended June 30, 2025, and to $299.7 million for the six months ended June 30, 2025, compared to the same periods in 2024.
  • Vita Coco Coconut Water net sales grew significantly by 24.8% in Q2 and 25.0% in H1, driven by strong volume increases of 20.9% and 22.7% respectively.
  • Private Label net sales decreased 36.5% in Q2 and 24.3% in H1, primarily due to the loss of private label coconut water service regions and the discontinuation of private label coconut oil business.
  • Consolidated gross profit increased 4.3% to $61.3 million in Q2 and 3.2% to $109.4 million in H1.
  • Consolidated gross margin decreased to 36.3% in Q2 2025 from 40.8% in Q2 2024, and to 36.5% in H1 2025 from 41.4% in H1 2024, primarily due to higher finished goods and transportation costs, and the initial impact of baseline tariffs.
  • Selling, General and Administrative (SG&A) expenses increased 25.7% to $36.1 million in Q2 and 14.0% to $64.9 million in H1, driven by marketing for Vita Coco Treats, personnel costs, and higher bad debt reserves.
  • Income from operations decreased 16.3% to $25.1 million in Q2 and 9.2% to $44.4 million in H1.
  • Net income increased 19.9% to $22.9 million in Q2 and 25.4% to $41.8 million in H1, benefiting from unrealized gains on derivative instruments.
  • Diluted Earnings Per Share (EPS) rose to $0.38 in Q2 and $0.70 in H1.
  • Cash provided by operating activities decreased 54.9% to $12.0 million for the six months ended June 30, 2025, primarily due to timing differences in accounts receivable collection and higher inventory purchases.
  • The share repurchase program was increased by an additional $25.0 million, totaling $65.0 million, with $42.1 million remaining as of June 30, 2025.

Sentiment

Score: 6

Explanation: While the company achieved strong top-line revenue growth driven by its core Vita Coco Coconut Water brand, profitability metrics like gross margin and income from operations declined due to increased costs and tariffs. Operating cash flow also saw a significant decrease. The expansion of the share repurchase program is positive, but the substantial decline in private label sales and the block sale by a major shareholder introduce elements of concern, leading to a mixed but slightly positive sentiment.

Positives

  • Strong net sales growth of 17.1% for both the three and six months ended June 30, 2025, demonstrating continued top-line expansion.
  • Vita Coco Coconut Water product category showed robust growth, with net sales increasing 24.8% in Q2 and 25.0% in H1, driven by significant volume increases of 20.9% and 22.7% respectively, indicating strong brand demand.
  • International segment net sales increased substantially by 36.6% in Q2 and 28.1% in H1, primarily from growth in Germany and the United Kingdom, highlighting successful international expansion.
  • Net income increased by 19.9% in Q2 and 25.4% in H1, partly due to favorable unrealized gains on derivative instruments.
  • Diluted EPS increased to $0.38 in Q2 and $0.70 in H1, reflecting improved earnings per share.
  • The share repurchase program was expanded by $25.0 million to a total of $65.0 million, with $42.1 million remaining, signaling management's confidence and commitment to shareholder returns.
  • The 2020 Credit Facility maturity date was extended by five years to February 13, 2030, providing long-term financial flexibility and stability.
  • Successful national rollout of Vita Coco Treats in the U.S., contributing significantly to 'Other' product category growth.

Negatives

  • Consolidated gross margin decreased by 4.5 percentage points in Q2 (to 36.3%) and 4.9 percentage points in H1 (to 36.5%) due to higher finished goods and transportation costs, and the initial impact of baseline tariffs.
  • Private Label net sales significantly declined by 36.5% in Q2 and 24.3% in H1, attributed to the loss of private label coconut water service regions and the discontinuation of private label coconut oil business.
  • Income from operations decreased by 16.3% in Q2 and 9.2% in H1, despite strong top-line growth, indicating increased operating expenses and margin pressures.
  • Cash provided by operating activities decreased by 54.9% to $12.0 million for the six months ended June 30, 2025, driven by timing differences in accounts receivable collection and higher inventory purchases, indicating reduced operational cash efficiency.
  • Increased Selling, General and Administrative (SG&A) expenses, up 25.7% in Q2 and 14.0% in H1, due to higher marketing spend, personnel costs, and bad debt reserves.
  • Interest income decreased due to lower interest rates in 2025 compared to 2024.

Risks

  • Uncertainty in the macroeconomic environment, including geopolitical and economic instability, wars, international conflicts, and variability in interest rates, foreign exchange rates, tariffs, and inflationary costs, may adversely affect the global supply chain.
  • Imposition of a new universal baseline tariff of 10% on all U.S. imports (effective April 2, 2025) has increased cost of goods sold, with uncertainty regarding its long-term application and potential for additional country-specific tariffs (e.g., 50% proposed for Brazil).
  • Potential disturbances in ocean shipping capacity and inflationary effects on costs due to tariff uncertainty.
  • Loss of private label business, including the discontinuation of private label coconut oil in early 2024 and loss of private label coconut water service regions starting Q2 2025, impacting net sales.
  • Concentration of credit risk with two major customers accounting for 45% of consolidated net sales and 44% of total accounts receivable for the six months ended June 30, 2025.
  • Reliance on a diversified global network of 16 factories across six countries for coconut water sourcing, exposing the company to potential instability in these regions.
  • Exposure to foreign currency risks from inventory purchases (Brazilian real, Malaysian ringgit, Thai baht) and intercompany transactions (British pounds, Canadian dollars, Euros).

Future Outlook

Management believes current cash, cash equivalents, future cash flows from operating activities, and available credit under the 2020 Credit Facility will be sufficient to meet anticipated cash needs for at least 12 months and the foreseeable future. The company may seek additional equity or debt financing in the future to acquire or invest in complementary businesses, products, and/or new IT infrastructures. The company is assuming for business operations that the 10% baseline tariffs will be in effect indefinitely, but the uncertainty around long-term tariff rates presents significant challenges. Private label coconut water net sales in 2025 are expected to be impacted by the loss of some regions, which started primarily in the second quarter of 2025.

Management Comments

  • Our mission is to deliver great tasting, natural and nutritious products that we believe are better for consumers and better for the world.
  • Our asset-lite operating model has historically provided us with a low cost, nimble, and scalable supply chain, which allows us to adapt to changes in the market or consumer preferences while also efficiently introducing new products across our platform.

Industry Context

The company operates in the dynamic coconut and plant-based water category, with its Vita Coco brand maintaining a leading position in the U.S. coconut water market. The strong growth in branded products reflects continued consumer demand for natural and healthy beverages. However, the challenges posed by new tariffs and increased transportation costs are indicative of broader global supply chain disruptions and inflationary pressures impacting the consumer goods industry. The decline in the private label business suggests evolving competitive dynamics or strategic shifts within that segment of the beverage market.

Comparison to Industry Standards

  • The company's asset-lite operating model is highlighted as a strategic advantage, suggesting a more flexible and potentially lower-cost structure compared to more vertically integrated competitors in the beverage industry.
  • The robust growth in branded Vita Coco coconut water indicates that the company is either gaining significant market share or outperforming the overall growth rate of the coconut water segment, particularly in the Americas and Europe.
  • The gross margin compression experienced by the company is a common challenge across the consumer goods sector, reflecting widespread inflationary pressures on raw materials, manufacturing, and logistics, suggesting the company is not immune to these broader industry trends.
  • While specific comparable companies or projects are not detailed in the filing, the company's ability to increase net income despite declining operating income and gross margin suggests effective financial management or other income streams that may differentiate its performance within the industry.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerNACorey BakerMay 12, 2025Adopted Rule 10b5-1 trading plan for sale of securities.
Co-Founder, Executive Chairman and Chairman of the BoardNAMichael Kirban (via The Michael Kirban 2012 Trust)June 5, 2025Adopted Rule 10b5-1 trading plan for sale of securities.
DirectorNAIra LiranMay 7, 2025Adopted Rule 10b5-1 trading plan for sale of securities.
Chief Sales OfficerNACharles Van EsJune 13, 2025Adopted Rule 10b5-1 trading plan for sale of securities.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director Compensation ArrangementThe nominee agreement between a Board member (appointed by Verlinvest Beverages SA) and Verlinvest, which directed the company to pay cash and equity compensation to Verlinvest, terminated. The director will now receive all compensation directly.June 3, 2025Simplifies compensation flow for the director; no direct impact on company's financial obligations or overall governance structure beyond this specific arrangement.

Legal Proceedings

  • Not currently a party to any material legal proceedings.

Related Party Transactions

  • A director nominee agreement with Verlinvest Beverages SA terminated on June 3, 2025, after which the director will receive compensation directly instead of it being paid to Verlinvest.
  • Verlinvest Beverages SA waived its right to reimbursement of legal fees totaling $140,000 in Q4 2023 and $324,000 in April 2024, related to secondary share offerings.
  • Verlinvest Beverages SA, a significant stockholder, completed a block sale of 3,766,762 shares of common stock at $34.25 per share on May 8, 2025, reducing its beneficial ownership from 19.1% to 12.5%. This transaction does not affect the company's capital structure or operations.
  • One major customer, who accounted for 20% of net sales and 23% of accounts receivable for the six months ended June 30, 2025, acquired less than 5% ownership at the IPO and was granted 200,000 restricted stock awards, which fully vested by March 31, 2024. This customer monetized its investment in Q1 2025.

Stakeholder Impact

  • Shareholders: Mixed impact due to strong branded sales growth offset by gross margin compression, declining operating income, and reduced operating cash flow. The expanded share repurchase program is positive, but the significant block sale by a major shareholder (Verlinvest) might raise questions.
  • Employees: Personnel-related expenses increased, suggesting continued investment in the workforce. Stock-based compensation programs are ongoing.
  • Customers: Continued strong demand for Vita Coco Coconut Water. However, the loss of private label business regions for multiple customers indicates a shift in customer relationships or competitive landscape in that segment.
  • Suppliers: The company relies on a diversified global network of 16 factories across six countries and has major supplier concentrations. The extension of the manufacturing agreement with Century Pacific Agricultural Ventures, Inc. until December 2030 indicates stable long-term relationships with key suppliers.
  • Creditors: The company has an immaterial amount of debt outstanding and was in compliance with all financial covenants under its $60 million revolving credit facility, which was extended to 2030, indicating good financial health from a credit perspective.

Next Steps

  • Monitor the impact of ongoing macroeconomic uncertainties, including geopolitical and economic instability, interest rates, foreign exchange rates, and tariffs, on the global supply chain and costs.
  • Evaluate the impact of adopting new accounting standard ASU 2024-03 (Income Statement Expense Disaggregation) effective for fiscal years beginning after December 15, 2026.
  • Manufacturer to promote the company's sustainability objectives and use commercially reasonable efforts to adopt policies and measures on ESG guidance targets.
  • Manufacturer to undergo annual Sedex Members Ethical Trade Audit (SMETA) and provide reports.
  • Manufacturer to collect, maintain, and provide applicable and accurate production data to the company's Laboratory Information Management System (LIMS) and Environmental Management System (EMS).
  • Potential future equity or debt financing to acquire or invest in complementary businesses, products, and/or new IT infrastructures.
  • Continued monitoring of the private label business decline and its impact on overall sales.

Key Dates

DateDescription
September 19, 2012Initial Manufacturing and Purchasing Agreement with Century Pacific Agricultural Ventures, Inc.
November 5, 2014Supplemental Agreement to Manufacturing and Purchasing Agreement.
November 30, 2015First Amendment to Manufacturing and Purchasing Agreement.
June 2018Acquisition date associated with all of the Company's goodwill.
May 2020Company entered into a five-year credit facility with Wells Fargo Bank, National Association (2020 Credit Facility).
October 2021Company completed its Initial Public Offering (IPO) and stockholders approved the 2021 Incentive Award Plan.
December 2022Borrowings on the 2020 Credit Facility began bearing interest at rates based on SOFR.
March 31, 202350% of restricted stock awards granted to a major customer at IPO vested.
May 2023Secondary share offering by Verlinvest, who waived legal fee reimbursement in Q4 2023.
October 30, 2023Company's Board approved a share repurchase program of up to $40.0 million.
November 2023Secondary share offering by Verlinvest, who waived legal fee reimbursement in April 2024.
December 2023Ceased selling Runa, a plant-based energy drink.
January 1, 2024Board elected not to increase shares available for the 2021 Plan for the year beginning this date.
early 2024Private label coconut oil business with a major customer discontinued.
March 31, 2024Remaining 50% of restricted stock awards granted to a major customer at IPO vested.
April 2024Verlinvest waived right to reimbursement of legal fees ($324k) for its counsel related to November 2023 secondary share offering.
August 2, 2024Company acquired a 60% joint venture interest in Coco Ventures Limited, obtaining significant influence.
August 31, 2024Company signed a lease agreement for a new office in New York, New York.
November 2024Company signed a lease agreement for a new office in London, United Kingdom.
December 15, 2024Effective date for ASU 2023-07 (Segment Reporting) for fiscal years beginning after this date.
December 31, 2024Fiscal year end for which audited consolidated financial statements were filed in Form 10-K.
January 1, 2025Operating lease for new New York office commenced.
January 2, 2025Operating lease for new London office commenced.
February 2025Coco Ventures Limited (joint venture in China) commenced operations.
February 14, 20252020 Credit Facility amended, extending maturity date to February 13, 2030.
April 1, 2025Operating lease for new Singapore office commenced.
April 2, 2025U.S. announced a new universal baseline tariff of 10% on all U.S. imports.
April 28, 2025Company's Board approved an additional $25.0 million to the share repurchase program, increasing total authorization to $65.0 million.
May 7, 2025Ira Liran and The Ira Liran 2012 Family Trust adopted Rule 10b5-1 trading plans.
May 8, 2025Verlinvest Beverages SA completed a block sale of 3,766,762 shares of common stock at $34.25 per share.
May 12, 2025Corey Baker (CFO) adopted a Rule 10b5-1 trading plan.
June 3, 2025Director nominee agreement with Verlinvest Beverages SA terminated.
June 5, 2025The Michael Kirban 2012 Trust adopted a Rule 10b5-1 trading plan.
June 12, 2025Third Amendment to the Manufacturing and Purchasing Agreement with Century Pacific Agricultural Ventures, Inc. signed.
June 13, 2025Charles Van Es (Chief Sales Officer) adopted a Rule 10b5-1 trading plan.
June 30, 2025End of the current reporting period for this 10-Q filing.
July 4, 2025United States enacted tax reform legislation (H.R.1, One Big Beautiful Bill Act).
July 28, 2025Number of common shares outstanding reported as 56,822,981.
July 30, 2025Date of signing for the Quarterly Report on Form 10-Q.
August 8, 2025Start date for Ira Liran's and The Ira Liran 2012 Family Trust's Rule 10b5-1 trading plans.
August 11, 2025Start date for Corey Baker's Rule 10b5-1 trading plan.
September 4, 2025Start date for The Michael Kirban 2012 Trust's Rule 10b5-1 trading plan.
September 12, 2025Start date for Charles Van Es's Rule 10b5-1 trading plan.
October 31, 2025Extended expiration date of the Company's existing New York office lease.
June 10, 2026Extended distributor agreement term with a significant customer.
December 15, 2026Effective date for ASU 2024-03 (Income Statement Expense Disaggregation) for fiscal years beginning after this date.
February 13, 2030Extended maturity date of the 2020 Credit Facility.
June 2030Termination date for new Singapore office operating lease.
December 2030Termination date for new London office operating lease and extended term end date for Manufacturing and Purchasing Agreement with Century Pacific Agricultural Ventures, Inc.
December 2034End date for new New York office operating lease.

Recommendation

hold

The Vita Coco Company demonstrates strong top-line growth in its core branded coconut water segment, indicating robust consumer demand and market leadership. However, this growth is overshadowed by significant gross margin compression due to rising costs and the impact of new tariffs, leading to a decline in operating income and a substantial reduction in cash flow from operations. The ongoing loss of private label business also presents a headwind. While the company's balance sheet remains strong with ample cash and an extended credit facility, and the expanded share repurchase program is a positive signal for capital allocation, the mixed financial performance and external pressures (tariffs, inflation) warrant a cautious approach. The recent large block sale by a significant shareholder (Verlinvest) could also introduce market uncertainty. Therefore, a 'hold' recommendation is appropriate, advising investors to monitor how the company navigates these cost and private label challenges while sustaining its core brand's growth.

Keywords

Coconut Water, Beverages, Consumer Goods, SEC Filing, Quarterly Report, Financial Results, Supply Chain, Tariffs, Private Label, Vita Coco, COCO, Soft Drinks, Healthy Beverages, Functional Beverages, Global Markets, North America, Europe, Asia Pacific, Earnings, Gross Margin, Cash Flow, Share Repurchase, Derivatives, Foreign Exchange Risk, Inflation, Public Benefit Corporation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.